📣 VC round data is live. Check it out!
- Public Comps
- Savaria
Savaria Valuation Multiples
Discover revenue and EBITDA valuation multiples for Savaria and similar public comparables like OC Oerlikon Corp, Immunocore Holdings, SonoScape, Enovis and more.
Savaria Overview
About Savaria
Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility and Patient Care. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market. It derives maximum revenue from Accessibility segment.
Founded
1999
HQ

Employees
2.4K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialSavaria Financials
Savaria reported last 12-month revenue of $684M and EBITDA of $141M.
In the same LTM period, Savaria generated $263M in gross profit, $141M in EBITDA, and $58M in net income.
Revenue (LTM)
Savaria P&L
In the most recent fiscal year, Savaria reported revenue of $668M and EBITDA of $136M.
Savaria is profitable as of last fiscal year, with gross margin of 39%, EBITDA margin of 20%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
Savaria Stock Performance
Savaria has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Savaria's stock price is $20.61.
Savaria share price decreased by 5.7% in the last 30 days.
Savaria has an EPS (earnings per share) of $0.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 1.2% | -5.7% | 12.1% | — | $0.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSavaria Valuation Multiples
Savaria trades at 2.4x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
Savaria Financial Valuation Multiples
As of May 13, 2026, Savaria has market cap of $1B and EV of $2B.
Savaria has a P/E ratio of 25.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Savaria Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Savaria Margins & Growth Rates
Savaria grew revenue by 7% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Savaria reported gross margin of 39%, EBITDA margin of 20%, and net margin of 8%.
Savaria Margins
Savaria Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Savaria Operational KPIs
Savaria's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Savaria's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Savaria's Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Savaria Competitors
Savaria competitors include OC Oerlikon Corp, Immunocore Holdings, SonoScape, Enovis, Nihon Kohden, 4DMedical, Nakanishi, Oxford Nanopore Technologies, AdaptHealth and Palfinger.
Most Savaria public comparables operate across Medical Devices and Machinery.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.6x | 1.6x | 9.1x | 9.0x | |||
| 2.7x | 2.6x | (295.3x) | (42.9x) | |||
| 3.9x | 3.7x | 33.3x | 31.5x | |||
| 1.3x | 1.3x | 7.1x | 7.0x | |||
| 0.9x | 0.9x | 7.9x | 8.2x | |||
| 339.7x | 231.0x | (79.1x) | (22.0x) | |||
| 2.3x | 2.2x | 9.4x | 9.2x | |||
| 4.0x | 3.8x | (10.6x) | (12.1x) | |||
This data is available for Pro users. Sign up to see all Savaria competitors and their valuation data. Start Free Trial | ||||||
Savaria M&A Activity
Savaria has acquired 11 companies to date.
Last acquisition by Savaria was on February 9th 2026. Savaria acquired Baxter Residential Elevators for undisclosed valuation.
Latest Acquisitions by Savaria
| Description | Baxter Residential Elevators is a manufacturer designing and producing residential elevators and home lifts with customizable options for accessibility and aesthetics. | Western Elevator is a Kent-headquartered supplier and service provider for vertical transportation systems. The company installs and maintains traction elevators, hydraulic elevators, platform lifts, stairlifts, and dumbwaiters in residential homes, apartment buildings, and commercial properties. Based in Washington state since 1957, it conducts modernizations, code upgrades, and 24/7 repair services across the Pacific Northwest including Seattle and Tacoma areas. | Handicare is a Kista-headquartered supplier of mobility aids including stairlifts, lifting devices and vehicle adaptations for the elderly and disabled. The company distributes through dealers across Europe and North America, with operations in multiple countries including Sweden, Norway and the United States. | Silvalea is a UK-based innovator in patient handling equipment, renowned for the Parasilk in-situ transfer sling. The company designs and manufactures slings, hoists, and accessories that minimize skin shear during bed-to-chair transfers in hospitals and care homes. Established in 2005, Silvalea supplies NHS trusts and private facilities throughout the UK and Ireland with CE-marked products focused on pressure ulcer prevention. | |
| HQ Country | |||||
| HQ City | — | Vancouver | Luleå | Newton Abbot | |
| Deal Date | 9 Feb 2026 | 8 May 2025 | 27 Jan 2021 | 18 Jun 2019 | |
| Valuation | undisclosed | undisclosed | $386M | $6M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Savaria acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Savaria
| When was Savaria founded? | Savaria was founded in 1999. |
| Where is Savaria headquartered? | Savaria is headquartered in Canada. |
| How many employees does Savaria have? | As of today, Savaria has over 2K employees. |
| Is Savaria publicly listed? | Yes, Savaria is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Savaria? | Savaria trades under SIS ticker. |
| When did Savaria go public? | Savaria went public in 2003. |
| Who are competitors of Savaria? | Savaria main competitors include OC Oerlikon Corp, Immunocore Holdings, SonoScape, Enovis, Nihon Kohden, 4DMedical, Nakanishi, Oxford Nanopore Technologies, AdaptHealth, Palfinger. |
| What is the current market cap of Savaria? | Savaria's current market cap is $1B. |
| What is the current revenue of Savaria? | Savaria's last 12 months revenue is $684M. |
| What is the current revenue growth of Savaria? | Savaria revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Savaria? | Current revenue multiple of Savaria is 2.4x. |
| Is Savaria profitable? | Yes, Savaria is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Savaria? | Savaria's last 12 months EBITDA is $141M. |
| What is Savaria's EBITDA margin? | Savaria's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Savaria? | Current EBITDA multiple of Savaria is 11.4x. |
| What is the current FCF of Savaria? | Savaria's last 12 months FCF is $74M. |
| What is Savaria's FCF margin? | Savaria's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Savaria? | Current FCF multiple of Savaria is 21.8x. |
| How many companies Savaria has acquired to date? | As of May 2026, Savaria has acquired 11 companies. |
| What was the largest acquisition by Savaria? | $386M acquisition of Handicare on 27th January 2021 was the largest M&A Savaria has done to date. |
| What companies Savaria acquired? | Savaria acquired Handicare, Span America, Garaventa Lift, Silvalea, Florida Lifts, Visilift, Silver Cross, Premier Lifts, H.E.S. Elevator Services Inc, Baxter Residential Elevators, and 1 other company. |
| In how many companies Savaria has invested to date? | Savaria hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Savaria
Lists including Savaria
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



